Bioengineered Proteins Drugs Market Report

China Bioengineered Proteins Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：146
  • REPORT CODE：GMM1758881
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Bioengineered Proteins Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Fresenius Kabi

    • Eli Lilly

    • Bayer

    • Hoffman-la-Roche

    • Merck

    • Baxter

    • GlaxoSmithKline

    • Johnson & Johnson

    • Abbot

    By Type:

    • Cytokines and Chemokines

    • Therapeutic Enzymes

    • Vaccines

    • Peptide Hormones

    • Monoclonal Antibodies

    • Peptide Antibiotics

    • Other

    By Application:

    • Others

    • Organ Transplants

    • Cancers

    • Diabetes and Hormonal Disorders

    • Genetic and Fertility Disorders

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Bioengineered Proteins Drugs Market Overview 2018-2029

    • 1.1 China Bioengineered Proteins Drugs Industry Development Overview

    • 1.2 China Bioengineered Proteins Drugs Industry Development History

    • 1.3 China Bioengineered Proteins Drugs Industry Market Size (2018-2029)

    • 1.4 China Bioengineered Proteins Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Cytokines and Chemokines (2018-2029)

      • 1.4.2 China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Therapeutic Enzymes (2018-2029)

      • 1.4.3 China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)

      • 1.4.4 China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Peptide Hormones (2018-2029)

      • 1.4.5 China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

      • 1.4.6 China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Peptide Antibiotics (2018-2029)

      • 1.4.7 China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • 1.5 China Bioengineered Proteins Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Bioengineered Proteins Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Bioengineered Proteins Drugs Sales Volume, Sales Value and Growth Rate of Organ Transplants (2018-2029)

      • 1.5.3 China Bioengineered Proteins Drugs Sales Volume, Sales Value and Growth Rate of Cancers (2018-2029)

      • 1.5.4 China Bioengineered Proteins Drugs Sales Volume, Sales Value and Growth Rate of Diabetes and Hormonal Disorders (2018-2029)

      • 1.5.5 China Bioengineered Proteins Drugs Sales Volume, Sales Value and Growth Rate of Genetic and Fertility Disorders (2018-2029)

    • 1.6 China Bioengineered Proteins Drugs Market Analysis by Region

      • 1.6.1 North China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Bioengineered Proteins Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Bioengineered Proteins Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Bioengineered Proteins Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Bioengineered Proteins Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Bioengineered Proteins Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Bioengineered Proteins Drugs Industry Development

    Chapter 3 Bioengineered Proteins DrugsIndustry Chain Analysis

    • 3.1 Bioengineered Proteins Drugs Industry Chain

    • 3.2 Bioengineered Proteins Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Bioengineered Proteins Drugs Market

    • 3.3 Bioengineered Proteins Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Bioengineered Proteins Drugs Market

    Chapter 4 China Bioengineered Proteins Drugs Market, by Type

    • 4.1 China Bioengineered Proteins Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Bioengineered Proteins Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Bioengineered Proteins Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Bioengineered Proteins Drugs Production Volume and Growth Rate of Cytokines and Chemokines

      • 4.5.2 China Bioengineered Proteins Drugs Production Volume and Growth Rate of Therapeutic Enzymes

      • 4.5.3 China Bioengineered Proteins Drugs Production Volume and Growth Rate of Vaccines

      • 4.5.4 China Bioengineered Proteins Drugs Production Volume and Growth Rate of Peptide Hormones

      • 4.5.5 China Bioengineered Proteins Drugs Production Volume and Growth Rate of Monoclonal Antibodies

      • 4.5.6 China Bioengineered Proteins Drugs Production Volume and Growth Rate of Peptide Antibiotics

      • 4.5.7 China Bioengineered Proteins Drugs Production Volume and Growth Rate of Other

    Chapter 5 China Bioengineered Proteins Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Bioengineered Proteins Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Bioengineered Proteins Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Bioengineered Proteins Drugs Market Size and Growth Rate of Others

      • 5.5.2 China Bioengineered Proteins Drugs Market Size and Growth Rate of Organ Transplants

      • 5.5.3 China Bioengineered Proteins Drugs Market Size and Growth Rate of Cancers

      • 5.5.4 China Bioengineered Proteins Drugs Market Size and Growth Rate of Diabetes and Hormonal Disorders

      • 5.5.5 China Bioengineered Proteins Drugs Market Size and Growth Rate of Genetic and Fertility Disorders

    Chapter 6 China Bioengineered Proteins Drugs Market, by Region

    • 6.1 China Bioengineered Proteins Drugs Production Volume and Production Value, by Region

    • 6.2 China Bioengineered Proteins Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Bioengineered Proteins Drugs Market Analysis

    • 7.1 North China Bioengineered Proteins Drugs Market, by Type

    • 7.2 North China Bioengineered Proteins Drugs Market, by Application

    Chapter 8 Central China Bioengineered Proteins Drugs Market Analysis

    • 8.1 Central China Bioengineered Proteins Drugs Market, by Type

    • 8.2 Central China Bioengineered Proteins Drugs Market, by Application

    Chapter 9 South China Bioengineered Proteins Drugs Market Analysis

    • 9.1 South China Bioengineered Proteins Drugs Market, by Type

    • 9.2 South China Bioengineered Proteins Drugs Market, by Application

    Chapter 10 East China Bioengineered Proteins Drugs Market Analysis

    • 10.1 East China Bioengineered Proteins Drugs Market, by Type

    • 10.2 East China Bioengineered Proteins Drugs Market, by Application

    Chapter 11 Northeast China Bioengineered Proteins Drugs Market Analysis

    • 11.1 Northeast China Bioengineered Proteins Drugs Market, by Type

    • 11.2 Northeast China Bioengineered Proteins Drugs Market, by Application

    Chapter 12 Southwest China Bioengineered Proteins Drugs Market Analysis

    • 12.1 Southwest China Bioengineered Proteins Drugs Market, by Type

    • 12.2 Southwest China Bioengineered Proteins Drugs Market, by Application

    Chapter 13 Northwest China Bioengineered Proteins Drugs Market Analysis

    • 13.1 Northwest China Bioengineered Proteins Drugs Market, by Type

    • 13.2 Northwest China Bioengineered Proteins Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Fresenius Kabi

        • 14.1.1 Fresenius Kabi Company Profile

        • 14.1.2 Fresenius Kabi Bioengineered Proteins Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Eli Lilly

        • 14.2.1 Eli Lilly Company Profile

        • 14.2.2 Eli Lilly Bioengineered Proteins Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Bayer

        • 14.3.1 Bayer Company Profile

        • 14.3.2 Bayer Bioengineered Proteins Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Hoffman-la-Roche

        • 14.4.1 Hoffman-la-Roche Company Profile

        • 14.4.2 Hoffman-la-Roche Bioengineered Proteins Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Merck

        • 14.5.1 Merck Company Profile

        • 14.5.2 Merck Bioengineered Proteins Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Baxter

        • 14.6.1 Baxter Company Profile

        • 14.6.2 Baxter Bioengineered Proteins Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 GlaxoSmithKline

        • 14.7.1 GlaxoSmithKline Company Profile

        • 14.7.2 GlaxoSmithKline Bioengineered Proteins Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Johnson & Johnson

        • 14.8.1 Johnson & Johnson Company Profile

        • 14.8.2 Johnson & Johnson Bioengineered Proteins Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Abbot

        • 14.9.1 Abbot Company Profile

        • 14.9.2 Abbot Bioengineered Proteins Drugs Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Bioengineered Proteins Drugs Industry Research Conclusions

    • 15.2 Bioengineered Proteins Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Bioengineered Proteins Drugs Industry Market Size (2018-2029)

    • Figure China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Cytokines and Chemokines (2018-2029)

    • Figure China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Therapeutic Enzymes (2018-2029)

    • Figure China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)

    • Figure China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Peptide Hormones (2018-2029)

    • Figure China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

    • Figure China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Peptide Antibiotics (2018-2029)

    • Figure China Bioengineered Proteins Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Bioengineered Proteins Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Bioengineered Proteins Drugs Sales Volume, Sales Value and Growth Rate of Organ Transplants (2018-2029)

    • Figure China Bioengineered Proteins Drugs Sales Volume, Sales Value and Growth Rate of Cancers (2018-2029)

    • Figure China Bioengineered Proteins Drugs Sales Volume, Sales Value and Growth Rate of Diabetes and Hormonal Disorders (2018-2029)

    • Figure China Bioengineered Proteins Drugs Sales Volume, Sales Value and Growth Rate of Genetic and Fertility Disorders (2018-2029)

    • Figure North China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Bioengineered Proteins Drugs Market Size and Growth Rate from 2018-2029

    • Figure Bioengineered Proteins Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Bioengineered Proteins Drugs Market Share by Type in 2018

    • Figure China Bioengineered Proteins Drugs Market Share by Type in 2023

    • Figure China Bioengineered Proteins Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Bioengineered Proteins Drugs Production Volume and Growth Rate of Cytokines and Chemokines (2018-2023)

    • Figure China Bioengineered Proteins Drugs Production Volume and Growth Rate of Therapeutic Enzymes (2018-2023)

    • Figure China Bioengineered Proteins Drugs Production Volume and Growth Rate of Vaccines (2018-2023)

    • Figure China Bioengineered Proteins Drugs Production Volume and Growth Rate of Peptide Hormones (2018-2023)

    • Figure China Bioengineered Proteins Drugs Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)

    • Figure China Bioengineered Proteins Drugs Production Volume and Growth Rate of Peptide Antibiotics (2018-2023)

    • Figure China Bioengineered Proteins Drugs Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Bioengineered Proteins Drugs Market Share by Application in 2018

    • Figure China Bioengineered Proteins Drugs Market Share by Application in 2023

    • Figure China Bioengineered Proteins Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Bioengineered Proteins Drugs Market Size and Growth Rate of Others (2018-2023)

    • Figure China Bioengineered Proteins Drugs Market Size and Growth Rate of Organ Transplants (2018-2023)

    • Figure China Bioengineered Proteins Drugs Market Size and Growth Rate of Cancers (2018-2023)

    • Figure China Bioengineered Proteins Drugs Market Size and Growth Rate of Diabetes and Hormonal Disorders (2018-2023)

    • Figure China Bioengineered Proteins Drugs Market Size and Growth Rate of Genetic and Fertility Disorders (2018-2023)

    • Table China Bioengineered Proteins Drugs Production Volume by Region (2018-2023)

    • Table China Bioengineered Proteins Drugs Production Volume Share by Region (2018-2023)

    • Figure China Bioengineered Proteins Drugs Production Volume Share by Region (2018-2023)

    • Table China Bioengineered Proteins Drugs Production Value by Region (2018-2023)

    • Table China Bioengineered Proteins Drugs Production Value Share by Region (2018-2023)

    • Figure China Bioengineered Proteins Drugs Production Value Share by Region (2018-2023)

    • Table China Bioengineered Proteins Drugs Sales Volume by Region (2018-2023)

    • Table China Bioengineered Proteins Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Bioengineered Proteins Drugs Sales Volume Share by Region (2018-2023)

    • Table China Bioengineered Proteins Drugs Sales Value by Region (2018-2023)

    • Table China Bioengineered Proteins Drugs Sales Value Share by Region (2018-2023)

    • Figure China Bioengineered Proteins Drugs Sales Value Share by Region (2018-2023)

    • Table North China Bioengineered Proteins Drugs Production Volume by Type (2018-2023)

    • Table North China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Table North China Bioengineered Proteins Drugs Sales Volume by Application (2018-2023)

    • Table North China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Bioengineered Proteins Drugs Production Volume by Type (2018-2023)

    • Table Central China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Bioengineered Proteins Drugs Sales Volume by Application (2018-2023)

    • Table Central China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Bioengineered Proteins Drugs Production Volume by Type (2018-2023)

    • Table South China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Table South China Bioengineered Proteins Drugs Sales Volume by Application (2018-2023)

    • Table South China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Bioengineered Proteins Drugs Production Volume by Type (2018-2023)

    • Table East China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Table East China Bioengineered Proteins Drugs Sales Volume by Application (2018-2023)

    • Table East China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Bioengineered Proteins Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Bioengineered Proteins Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Bioengineered Proteins Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Bioengineered Proteins Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Bioengineered Proteins Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Bioengineered Proteins Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Bioengineered Proteins Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Bioengineered Proteins Drugs Sales Volume Share by Application (2018-2023)

    • Table Fresenius Kabi Company Profile

    • Table Fresenius Kabi Bioengineered Proteins Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Bioengineered Proteins Drugs Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Bioengineered Proteins Drugs Revenue, Price and Gross (2018-2023)

    • Table Hoffman-la-Roche Company Profile

    • Table Hoffman-la-Roche Bioengineered Proteins Drugs Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Bioengineered Proteins Drugs Revenue, Price and Gross (2018-2023)

    • Table Baxter Company Profile

    • Table Baxter Bioengineered Proteins Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Bioengineered Proteins Drugs Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Bioengineered Proteins Drugs Revenue, Price and Gross (2018-2023)

    • Table Abbot Company Profile

    • Table Abbot Bioengineered Proteins Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US